Activation of protein kinase C by an aromatic xenobiotic diacylglycerol analogue  by Moorhouse, Kathryn G. et al.
Volume 2.56, number I,& 43-46 FEB 07658 October 1989 
Activation of protein kinase C by an aromatic xenobiotic 
diacylglycerol analogue 
Kathryn G. Moorhouse, David H. Hutson* and Peter F. Dodds 
Department of Biochemistry and Biological Sciences, Wye College (University of London), Wye, Ashford, 
Kent TN25 5A H, England and *Shell Research Ltd. Sittingbourne Research Centre, Sittinghourne, Kent ME9 8AG, 
England 
Received 7August 1989 
A number of xenobiotic carboxylic acids, including 3-phenoxybenzoic acid (3PBA), have been shown to form ‘hybrid 
di- and tri-acylglycerols both in vivo and in vitro. Experiments were carried out to test the hypothesis that naturally 
occurring xenobiotic diacylglycerols may stimulate protein kinase C. The activity of protein kinase C was measured in 
the presence of different diacylglycerols. I-Acyl-2-(3PBA)-sn-glycerol but not 1,2-di-3PBA-sn-glycerol stimulated protein 
kinase C, but less effectively than either dioleoylglycerol or phorbol 12-myristate 13-acetate. The xenobiotic diacylglycer- 
01s were also more resistant o lipolysis. The possibility exists therefore that some xenobiotic diacylglycerols may behave, 
like phorbol diesters, as tumour promoters. 
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1. INTRODUCTION 
The importance of receptor-mediated hydrolysis 
of phosphatidyl inositol-4,5-b&phosphate to form 
the two intracellular signalling molecules, 
inositol-1,4,5-tris-phosphate and 1,2-diacyl-sn- 
glycerol (DG) is now well documented [l-3]. The 
DG ‘2nd messenger’ effect appears to be mediated 
via its action on protein kinase C (PKC). PKC is 
an enzyme found in inactive form in the cytosol of 
many cell types and in an active form associated 
with the plasma membrane. The transfer into the 
active, membrane-bound form requires calcium 
ions but is greatly stimulated by the presence of 
DG [4]. The structural requirements for the DG 
appear to be acyl groups at positions sn-1 and sn-2 
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and a free hydroxyl group at sn-3 [5]. Activation of 
PKC by synthetic DG has also been reported 
[f&9]. A number of phorbol diesters, which are 
structurally analogous to natural DG, also have ac- 
cess to the membrane where they are strong ac- 
tivators of PKC. This activation is prolonged and 
the resultant persistent imbalance in the action of 
the two second messengers may lead to a 
breakdown in cellular control which is 
characteristic of the tumour-promoting activity of 
the phorbol diesters IlO]. 
The incorporation of a range of xenobiotic 
alkyl, aralkyl and aryl, carboxylic acids into hybrid 
or xenobiotic di- and tri-acylglycerols is a recently, 
but now well established, minor route of 
metabolism for such compounds [ 1 l- 131. Biosyn- 
thetic [13] and structural [14] studies have shown 
that xenobiotic acids could occupy any one of the 
3 positions in triacylglycerol so xenobiotic DG 
must occur as intermediates in the biosynthesis. 
This paper tests the hypothesis that xenobiotic DG, 
derived by normal metabolic routes from drugs 
and other xenobiotic compounds may, like the 
phorbol diesters, stimulate PKC. 3-Phenoxy- 
benzoyl (3PBA)-containing DG were used as 
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model aromatic xenobiotic DC in the current 
study. 
2. MATERIALS AND METHODS 
[-Y-~‘P]ATP was obtained from Amersham International, 
Amersham, England. I-Acyl,2-(3-phenoxybenzoyl)~sn-glycerol 
(mono-3PBA-DG) was prepared from the corresponding 
phosphatidylchaline [IS]. The phosphatidylcholine had been 
prepared from egg lyso-phosphatidyl~holine and was supplied 
by Lipid Products, S. Nutfield, Surrey, England. 1,2-Di(3- 
phenoxybenzoyl)-sn-glycerol (di-3PBA-DC) was similarly 
prepared. All other chemicals and biochemicals were obtained 
from Sigma Chemical Co., Poole, England. 
2.1. Preparafiotl and assay of protein kinase C 
Partially purified PKC was prepared from the brains of five 
22-day-old male rats of the Wistar strain (obtained from 
Charles River UK Ltd, Ramsgate, England). The purification 
method of Niedel et al. [16] was followed as far as 
chromatography on DEAE-Sephacel. The peak eluting at 
0.15 M NaCl was subjected to gel chromatography on 
Sephadex G50 to remove EDTA and EGTA and this resulted in 
a further lo-fotd purification. The pooled active fractions were 
stored at 4°C for up to 7 days in the presence of 106 PM EGTA, 
50 mM mercaptoethanol, 0.1 mM phenylmethylsulphonyl 
fluoride, 1 mg/ml bovine serum albumin and 50pg/ml 
leupeptin. 
The standard assay [17] for PKC contained, in a final volume 
of 250~1, 1OpM [y-32P]ATP (135 Ci/mol), 1OOpM CaClz, 
10 m MgClz, 300pM phosphatidylserine from bovine brain 
(sonicated in 3% (w/v) Triton X-100), 430 ,uM DG (also in 3% 
Triton X-106) and 50 fig of histone (type III-S). Reactions were 
started by the addition of 50 pl of the enzyme preparation, in- 
cubated at 27°C for 10 min and stopped by the addition of 1 ml 
of ice-cold 10% (w/v) trichloroacetic acid containing 5 mM 
NaH2P04 and 2 mM ATP followed by 1 ml of 500 rgiml 
bovine serum albumin [lS]. After washing steps the protein was 
reprecipitated onto glass fibre filter discs and the radioactive 
content determined by liquid scintillation counting, using 
Aquasol- (DuPont UK Ltd, Stevenage, England) as scintillant. 
Ca’+-independent kinase activity was subtracted from the total 
kinase activity. 
2.2. Digestion of d~a~yi~lycero~s by ~ancreatjc lipase 
0.2 mg of dioieoylgly~erol r of mono-3PBA-DG were in- 
cubated with pancreatic lipase as described by Luddy et al. [ 191. 
The mixtures were incubated at 40°C until the reaction was 
stopped with 1 ml of 6 M HCl and the lipids extracted. After 
thin-layer chromatography on silica gel developed in hex- 
ane:diethyl ether:acetic acid (40:60: 1, v/v), the lipids were 
visualized by charring and estimated by scanning densitometry. 
The results were expressed as a percentage of DG remaining 
where the amount remaining at time = 0 was defined as 100%. 
3. RESULTS AND DISCUSSION 
The activity of the partially purified PKC was 
Ist-order with respect o time of incubation and to 
44 
protein concentration. It was shown to be depen- 
dent on phosphatidylserine and calcium ions and 
to be stimulated by dioIeoy~giy~ero1. Figs la and b 
show that the inclusion of 430 PM dioleoylglycerol 
in the assay resulted in a PKC activity of 
0.7 pmol/min. At this concentration the activity 
had not yet reached a plateau, The tumour- 
promoting phorbol diester, PMA, stimulated the 
PKC activity to 1.3 pmol/min at a concentration 
of only 100 nM. A separate xperiment using con- 
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Fig.1. Stimulation of PKC activity by naturat and xenobiotic 
diacylglycerols and by a phorbol diester. PKC was assayed in 
the presence of the indicated concentration of 1,2-dioleoyl-sn- 
glycerol (a), mono-3PBA-DG (A) or di-3PBA-DG (m) (fig.la) 
or of PMA (formulated in dimethyl sulphoxide and diluted with 
3% (w/v) bovine serum albumin) (fig. lb). Activities are quoted 
as pmol of phosphorus incorporated into protein/ruin per 50 ~1 
of undiluted enzyme solution. Error bars represent he mean i: 
SD from 3 independent preparations or mean +- range from 2. 
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centrations of PMA on a logarithmic scale showed 
no further increase in PKC activity between 
100 nM and 10 FM PMA. Fig.la shows that the 
xenobiotic DG, mono-3PBA-DC, also stimulated 
PKC over the range of concentrations used but to 
a lesser extent. Enzyme activity was still increasing 
at 430 FM mono-3PBA-DG. In contrast di-3PBA- 
DC did not appear to stimulate PKC at the concen- 
trations used. 
Phorbol diesters are thought to be resistant to 
degradation, a property which results in persistent 
stimulation of PKC [ 1,2]. As a preliminary assess- 
ment of the persistence of xenobiotic DG, the ac- 
tion of pancreatic Iipase upon dioleoylglycerol and 
on mono-3PBA-DG was compared (fig.2). ft can 
be seen that under the experimental conditions 
50% of the dioleoylglycerol had been digested in 
under 6 min, whereas 50 min was required to 
achieve 50% digestion of mono-3PBA-DG. 
Three criteria must be satisfied before a com- 
pound could be said to be behaving like the phor- 
bol diesters as tumour promoters. First the 
compound should be synthesized near, or other- 
wise have access to, the site of action. The biosyn- 
thesis of xenobiotic DG in the microsomal fraction 
of many cell types has already been described ([ 131 
and Moorhouse et al., manuscript in preparation). 
It can be presumed that some DG thus synthesized 
would be accessible to PKC. However, both the 
proportion metabolized by this route in vivo [14] 
and the rate of biosynthesis in vitro [13] are very 
low. Secondly, the compound must stimulate 
PKC. The results of this paper show that this is the 
case for diacylglycerols containing 3PBA in the 
sn-2 position, but not in both the sn-1 and sn-2 
positions. This stimulation, however, occurs at 
very much higher concentrations (about lo4 times 
higher) than those necessary with PMA. This 
observation alone suggests that the risk from the 
3PBA compound is much less than that from the 
phorbol diester. Thirdly, the rate of removal of the 
compound must be low to allow for persistence of 
the stimulation. This is a property that has not 
been measured directly: however, the findings us- 
ing pancreatic lipase reported here, and the results 
of Fears et al. 1201 suggest that the xenobiotic 
analogues are more resistant to some types of 
lipoiytic attack than natural DG. The possible role 
of DG kinase in recyclic xenobiotic DG has not 
been assessed. 
Fig.2. Digestion of diacylglycerols by pancreatic lipase. The 
substrates were dioleoylglycerol (0) or mono-3PBA-DG (A). 
In conclusion, we have shown that a class of 
metabolites of foreign compounds, already known 
to be produced in vivo and in vitro, have the poten- 
tial to behave like the phorbol diesters as tumour 
promoters. In the case examined here, 3PBA-DG, 
the activity is likely to be very low. However, no 
such judgement can be made about other 
xenobiotic-DG. This is an aspect of the 
metabolism of xenobiotic carboxylic acids which 
merits further attention. 
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